ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2163

Enhancing Post-Conference Engagement Through Expert Q&A: A Pilot Collaboration Between ACR Convergence & theMednet.org

Nina Couette1, Herveen Singh2, Melissa Briones3, Nadine Housri4 and Rebecca Manno5, 1The Ohio State University, Columbus, OH, 2theMednet.org, New York, NY, 3Loyola University, Maywood, IL, 4theMednet.org, New York, 5University of The Virgin Islands / The Arthritis and Rheumatology Center of the Caribbean, St. Thomas

Meeting: ACR Convergence 2025

Keywords: Education, education, medical, race/ethnicity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2159–2194) Professional Education Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: ACR Convergence is a key platform for sharing cutting-edge research and clinical insights in rheumatology. To extend the educational value of select sessions beyond the meeting itself, a pilot collaboration between ACR and theMednet.org was developed. The initiative, titled “Continue the Conversation,” aimed to foster enduring post-conference engagement. This was accomplished by posing timely clinical questions from ACR Convergence sessions to theMednet experts and distributing their answers, sometimes paired with interactive polls, via email to the broader rheumatology community.

Methods: Clinically relevant questions were curated by theMednet editorial team based on pre-selected presentations from ACR Convergence 2024. These questions were sent to experts (including session presenters) for commentary. Polls were created for some questions to encourage participation, and a custom ACR-specific program tag was added to promote visibility and searchability. Each question included contextual information and direct reference to the corresponding ACR session. The Q&A was disseminated via email newsletters over a 6-8 week period, and a comprehensive summary was shared with physicians at the end of the program. Engagement metrics were tracked across multiple domains. CME credit claims were also reviewed.

Results: A total of nine questions and four polls were created based on the ACR Convergence presentations. During the program, 675 physicians engaged with Q&A content. The content reached a broad audience, with 4,845 total views across the nine questions with an average of 2.7 views per physician per question. Individual Q&A posts received an average of 538 views, and engagement with associated polls came from 201 unique voters with participation spanning 560 institutions (Image 1). Viewers spent an average of 12 minutes on the site viewing program content. Engagement was broad-based with poll participants and viewers representing diverse geographic regions and practice settings across rheumatology, pulmonology, and nephrology (Image 2). A total of 345 CME credits were claimed for 169 unique physicians. Of those claims, in regard toimpact on clinical practice, 37% of respondents stated they gained a deeper understanding of a topic, 37% learned something new, 10% stated they understand how to apply what they know to clinical practice, 8% stated there was no impact, and 8% responded “other” (Image 3).

Conclusion: The “Continue the Conversation” initiative effectively extended the impact of ACR Convergence 2024 by fostering sustained engagement with key clinical topics through expert-led Q&A on theMednet.org. High levels of participation, CME activity, and reported practice relevance demonstrate that digital platforms can play a critical role in translating conference content into lasting educational value. These findings support continued innovation in post-conference learning and highlight opportunities to further integrate digital engagement into future ACR educational strategies.

Supporting image 1Image 1: Summary of Engagement Per Question

Supporting image 2Image 2: Program Viewership

Supporting image 3Image 3: Impact on Clinical Practice


Disclosures: N. Couette: None; H. Singh: theMednet, 3; M. Briones: theMednet.org, 3, 8; N. Housri: Mednet, 8, 12, I do not believe this fits the definition of an ineligible company but I do want to disclose that I am the co-founder and Chief Medical Officer; R. Manno: None.

To cite this abstract in AMA style:

Couette N, Singh H, Briones M, Housri N, Manno R. Enhancing Post-Conference Engagement Through Expert Q&A: A Pilot Collaboration Between ACR Convergence & theMednet.org [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/enhancing-post-conference-engagement-through-expert-qa-a-pilot-collaboration-between-acr-convergence-themednet-org/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enhancing-post-conference-engagement-through-expert-qa-a-pilot-collaboration-between-acr-convergence-themednet-org/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology